vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and Construction Partners, Inc. (ROAD). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $809.5M, roughly 1.4× Construction Partners, Inc.). Construction Partners, Inc. runs the higher net margin — 2.1% vs -127.8%, a 129.9% gap on every dollar of revenue. On growth, Construction Partners, Inc. posted the faster year-over-year revenue change (44.1% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $47.1M). Over the past eight quarters, Construction Partners, Inc.'s revenue compounded faster (47.6% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Alexander Construction Company was a Palm Springs, California, residential development company that built over 2,200 houses in the Coachella Valley of Riverside County, California, between 1955 and 1965.
PRGO vs ROAD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $809.5M |
| Net Profit | $-1.4B | $17.2M |
| Gross Margin | 32.6% | 15.0% |
| Operating Margin | -116.0% | 6.2% |
| Net Margin | -127.8% | 2.1% |
| Revenue YoY | -2.5% | 44.1% |
| Net Profit YoY | -3093.9% | 663.9% |
| EPS (diluted) | $-10.23 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $809.5M | ||
| Q3 25 | $1.0B | $899.8M | ||
| Q2 25 | $1.1B | $779.3M | ||
| Q1 25 | $1.0B | $571.6M | ||
| Q4 24 | $1.1B | $561.6M | ||
| Q3 24 | $1.1B | $538.2M | ||
| Q2 24 | $1.1B | $517.8M | ||
| Q1 24 | $1.1B | $371.4M |
| Q4 25 | $-1.4B | $17.2M | ||
| Q3 25 | $7.5M | $56.6M | ||
| Q2 25 | $-8.4M | $44.0M | ||
| Q1 25 | $-6.4M | $4.2M | ||
| Q4 24 | $-44.4M | $-3.1M | ||
| Q3 24 | $-21.0M | $29.3M | ||
| Q2 24 | $-108.4M | $30.9M | ||
| Q1 24 | $2.0M | $-1.1M |
| Q4 25 | 32.6% | 15.0% | ||
| Q3 25 | 36.1% | 17.7% | ||
| Q2 25 | 34.4% | 16.9% | ||
| Q1 25 | 37.6% | 12.5% | ||
| Q4 24 | 33.9% | 13.6% | ||
| Q3 24 | 37.2% | 15.6% | ||
| Q2 24 | 37.0% | 16.1% | ||
| Q1 24 | 33.1% | 10.4% |
| Q4 25 | -116.0% | 6.2% | ||
| Q3 25 | 7.0% | 11.2% | ||
| Q2 25 | 4.3% | 10.6% | ||
| Q1 25 | 4.5% | 4.8% | ||
| Q4 24 | 10.0% | 2.5% | ||
| Q3 24 | 7.4% | 8.5% | ||
| Q2 24 | -2.5% | 8.8% | ||
| Q1 24 | -5.1% | 0.8% |
| Q4 25 | -127.8% | 2.1% | ||
| Q3 25 | 0.7% | 6.3% | ||
| Q2 25 | -0.8% | 5.7% | ||
| Q1 25 | -0.6% | 0.7% | ||
| Q4 24 | -3.9% | -0.5% | ||
| Q3 24 | -1.9% | 5.4% | ||
| Q2 24 | -10.2% | 6.0% | ||
| Q1 24 | 0.2% | -0.3% |
| Q4 25 | $-10.23 | $0.31 | ||
| Q3 25 | $0.05 | $1.03 | ||
| Q2 25 | $-0.06 | $0.79 | ||
| Q1 25 | $-0.05 | $0.08 | ||
| Q4 24 | $-0.32 | $-0.06 | ||
| Q3 24 | $-0.15 | $0.55 | ||
| Q2 24 | $-0.79 | $0.59 | ||
| Q1 24 | $0.01 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $104.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $969.1M |
| Total Assets | $8.5B | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $104.1M | ||
| Q3 25 | $432.1M | $156.1M | ||
| Q2 25 | $454.2M | $114.3M | ||
| Q1 25 | $409.9M | $101.9M | ||
| Q4 24 | $558.8M | $132.5M | ||
| Q3 24 | $1.5B | $74.7M | ||
| Q2 24 | $542.8M | $56.3M | ||
| Q1 24 | $658.5M | $48.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $515.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.9B | $969.1M | ||
| Q3 25 | $4.4B | $912.0M | ||
| Q2 25 | $4.5B | $853.3M | ||
| Q1 25 | $4.4B | $807.9M | ||
| Q4 24 | $4.3B | $811.1M | ||
| Q3 24 | $4.6B | $573.7M | ||
| Q2 24 | $4.5B | $552.9M | ||
| Q1 24 | $4.7B | $525.0M |
| Q4 25 | $8.5B | $3.4B | ||
| Q3 25 | $10.1B | $3.2B | ||
| Q2 25 | $10.1B | $2.9B | ||
| Q1 25 | $9.8B | $2.8B | ||
| Q4 24 | $9.6B | $2.6B | ||
| Q3 24 | $11.2B | $1.5B | ||
| Q2 24 | $10.4B | $1.4B | ||
| Q1 24 | $10.6B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.90× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $82.6M |
| Free Cash FlowOCF − Capex | $148.6M | $47.1M |
| FCF MarginFCF / Revenue | 13.4% | 5.8% |
| Capex IntensityCapex / Revenue | 2.4% | 4.4% |
| Cash ConversionOCF / Net Profit | — | 4.80× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $186.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $82.6M | ||
| Q3 25 | $51.7M | $112.0M | ||
| Q2 25 | $75.9M | $83.0M | ||
| Q1 25 | $-64.5M | $55.6M | ||
| Q4 24 | $312.6M | $40.7M | ||
| Q3 24 | $42.2M | $95.9M | ||
| Q2 24 | $9.5M | $34.6M | ||
| Q1 24 | $-1.4M | $18.2M |
| Q4 25 | $148.6M | $47.1M | ||
| Q3 25 | $29.8M | $78.9M | ||
| Q2 25 | $56.7M | $46.4M | ||
| Q1 25 | $-90.0M | $14.2M | ||
| Q4 24 | $274.9M | $13.8M | ||
| Q3 24 | $15.1M | $78.4M | ||
| Q2 24 | $-18.9M | $19.7M | ||
| Q1 24 | $-26.5M | $-10.6M |
| Q4 25 | 13.4% | 5.8% | ||
| Q3 25 | 2.9% | 8.8% | ||
| Q2 25 | 5.4% | 5.9% | ||
| Q1 25 | -8.6% | 2.5% | ||
| Q4 24 | 24.2% | 2.5% | ||
| Q3 24 | 1.4% | 14.6% | ||
| Q2 24 | -1.8% | 3.8% | ||
| Q1 24 | -2.4% | -2.8% |
| Q4 25 | 2.4% | 4.4% | ||
| Q3 25 | 2.1% | 3.7% | ||
| Q2 25 | 1.8% | 4.7% | ||
| Q1 25 | 2.4% | 7.2% | ||
| Q4 24 | 3.3% | 4.8% | ||
| Q3 24 | 2.5% | 3.3% | ||
| Q2 24 | 2.7% | 2.9% | ||
| Q1 24 | 2.3% | 7.7% |
| Q4 25 | — | 4.80× | ||
| Q3 25 | 6.89× | 1.98× | ||
| Q2 25 | — | 1.88× | ||
| Q1 25 | — | 13.20× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.27× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | -0.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
ROAD
Segment breakdown not available.
